Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 32 | 0 | 0 | 291 | 0 |
| Cost of Goods | 8 | N/A | N/A | 54 | N/A |
| Gross Profit | 25 | N/A | N/A | 236 | N/A |
| Operating Expenses | 17,720 | 13,367 | 11,431 | 13,090 | 16,492 |
| Operating Income | -17,687 | -13,367 | -11,431 | -12,799 | -16,492 |
| Other Income | 649 | -165 | -115 | 110 | 627 |
| Pre-tax Income | -17,038 | -13,532 | -11,546 | -12,689 | -15,864 |
| Income Tax | N/A | N/A | 2 | 0 | 0 |
| Net Income Continuous | -17,038 | -13,532 | -11,548 | -12,689 | -15,865 |
| Net Income | $-17,038 | $-13,532 | $-11,548 | $-12,689 | $-15,865 |
| EPS Basic Total Ops | -0.88 | -0.70 | -0.60 | -0.67 | -0.82 |
| EPS Basic Continuous Ops | -0.88 | -0.70 | -0.60 | -0.67 | -0.82 |
| EPS Diluted Total Ops | -0.88 | -0.70 | -0.60 | -0.67 | -0.82 |
| EPS Diluted Continuous Ops | -0.88 | -0.70 | -0.60 | -0.67 | -0.82 |
| EPS Diluted Before Non-Recurring Items | -0.88 | -0.70 | -0.59 | -0.65 | -0.82 |
| EBITDA(a) | $-15,995 | $-11,802 | $-9,838 | $-11,260 | $-15,052 |